Drug Profile
Research programme: protein inhibitors - ProMining Therapeutics
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator ProMining Therapeutics
- Class Small molecules
- Mechanism of Action Protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- No development reported Cancer; Cardiovascular disorders; Inflammation; Inflammatory pain
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Cancer in Israel (PO)
- 16 Jul 2016 No recent reports of development identified for research development in Cardiovascular-disorders in Israel (PO)
- 16 Jul 2016 No recent reports of development identified for research development in Inflammation in Israel (PO)